VASO Corp
VASOOTCCIK 839087HealthcareFiscal year ends Dec 31
Reports and events: 153 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2913:48 ET | DEF 14A | Proxy statementPeriod 2026-12-08 | 0001213900-26-113710 |
| 2026-08-1416:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090009 |
| 2026-08-0616:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-086128 |
| 2026-07-3117:01 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001213900-26-084076 |
| 2026-07-2317:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-080991 |
| 2026-05-1516:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057690 |
| 2026-05-0816:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-053854 |
| 2026-04-1609:03 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-044358 |
| 2026-04-1009:29 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-042214 |
| 2026-03-3117:25 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-037664 |
| 2026-02-1215:20 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-015515 |
| 2025-12-1910:55 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-123593 |
| 2025-11-2012:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-112966 |
| 2025-11-1416:41 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-110955 |
| 2025-11-0506:10 ET | DEF 14A | Proxy statementPeriod 2025-12-17 | 0001213900-25-106419 |
| 2025-08-1416:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076616 |
| 2025-05-1516:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-044213 |
| 2025-03-3116:46 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-026337 |
| 2025-01-0316:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-25-000753 |
| 2024-11-1416:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-098378 |
| 2024-09-1918:31 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-079992 |
| 2024-09-1017:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-077416 |
| 2024-08-2817:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-073043 |
| 2024-08-2316:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-072203 |
| 2024-08-1416:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068957 |
| 2024-08-0719:04 ET | DEF 14A | Proxy statementPeriod 2024-08-26 | 0001213900-24-065802 |
| 2024-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-043559 |
| 2024-04-0116:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-028734 |
| 2023-12-0820:42 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-015266 |
| 2023-11-1416:07 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001654954-23-014359 |
| 2023-08-1416:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001654954-23-010753 |
| 2023-05-1516:18 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001654954-23-006577 |
| 2023-04-0310:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-23-004199 |
| 2023-03-3117:30 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001654954-23-004142 |
| 2022-11-1416:17 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001654954-22-015274 |
| 2022-10-0316:03 ET | DEF 14A | Proxy statementPeriod 2022-11-15 | 0001654954-22-013242 |
| 2022-09-1616:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001654954-22-012632 |
| 2022-08-1516:25 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001654954-22-011378 |
| 2022-05-1616:08 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001654954-22-006968 |
| 2022-03-3116:08 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001654954-22-004333 |
| 2021-11-1516:07 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001654954-21-012209 |
| 2021-08-2709:15 ET | DEF 14A | Proxy statementPeriod 2021-10-12 | 0001654954-21-009494 |
| 2021-08-1616:52 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001654954-21-009103 |
| 2021-06-2506:02 ET | 8-K | 1.02 Termination of a material agreement | 0001654954-21-007266 |
| 2021-06-0415:17 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001654954-21-006610 |
| 2021-05-0517:34 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001654954-21-005117 |
| 2020-11-1316:06 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001654954-20-012351 |
| 2020-08-1416:02 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001654954-20-009163 |
| 2020-06-0416:01 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001654954-20-006323 |
| 2020-05-1416:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-20-005467 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 13:52 ET. Listed shows no prices and gives no investment advice.